Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava

被引:164
作者
Ahn, MJ
Yoon, KD
Min, SY
Lee, JS
Kim, JH
Kim, TG
Kim, SH
Kim, NG
Huh, H
Kim, J [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] Kyung Hee Univ, East West Med Res Inst, Res Grp Pain & Neurosci Vis 2000 Project, Seoul 130701, South Korea
[4] Sungkyunkwan Univ, Inst Nat Sci, Dept Biol Sci, Suwon 440746, South Korea
[5] Korea Food & Drug Adm, Natl Inst Toxicol Res, Seoul 122020, South Korea
[6] Gyeongsang Natl Univ, Dept Aquaculture, Tongyoung 660701, South Korea
关键词
Ecklonia cava; 8,8 '-bieckol; 8,4 '''-dieckol; HIV-1 reverse transcriptase; noncompetitive inhibition; protease;
D O I
10.1248/bpb.27.544
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The bioassay-directed isolation of a marine brown alga, Ecklonia cava, afforded four phlorotannin derivatives, eckol (1), 8,8'-bieckol (2), 8,4"'-dieckol (3), and phlorofucofuroeckol A (4). Among these compounds, 2 and 3 exhibited an inhibitory effect on human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease. Specifically, they inhibited the RT more potently than the protease. The inhibitory activity of compound 2 (IC50, 0.51 muM) against HIV-1 RT was comparable to that of nevirapine (IC50, 0.28 muM), a reference compound. An enzyme kinetic assay showed that this compound inhibited the RNA-dependent DNA synthesis activity of HIV-1 RT noncompetitively against dUTP/dTTP with a K-i value of 0.78 muM. With respect to the homopolymeric template/primer, (rA)(n)(dT)(15), 8,8'-bieckol (2) displayed an uncompetitive type of inhibition (K-i, 0.23 muM).
引用
收藏
页码:544 / 547
页数:4
相关论文
共 24 条
  • [1] Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts
    Ahn, MJ
    Yoon, KD
    Kim, CY
    Min, SY
    Kim, YU
    Kim, HJ
    Kim, JH
    Shin, CG
    Lee, CK
    Kim, TG
    Kim, SH
    Huh, H
    Kim, J
    [J]. JOURNAL OF APPLIED PHYCOLOGY, 2002, 14 (05) : 325 - 329
  • [2] CARROLL SS, 1993, J BIOL CHEM, V268, P276
  • [3] De Clercq E, 2000, MED RES REV, V20, P323, DOI 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO
  • [4] 2-A
  • [5] DEBYSER Z, 1992, MOL PHARMACOL, V41, P963
  • [6] HIV INHIBITORS TARGETED AT THE REVERSE-TRANSCRIPTASE
    DECLERCQ, E
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 119 - 137
  • [7] FRANK KB, 1991, J BIOL CHEM, V266, P19232
  • [8] FUKUYAMA Y, 1990, CHEM PHARM BULL, V38, P133
  • [9] FUKUYAMA Y, 1989, CHEM PHARM BULL, V37, P2438, DOI 10.1248/cpb.37.2438
  • [10] FUKUYAMA Y, 1995, CHEM LETT, P739